These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8697381)

  • 21. [Malignancy of colorectal cancer analyzed by expression of cyclin D1].
    Maeda K; Kang SM; Ogawa M; Chung YS; Onoda N; Nakata B; Nishiguchi Y; Ikehara T; Okuno M; Sowa M
    Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():259-62. PubMed ID: 9263512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
    Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
    Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
    Naidu R; Wahab NA; Yadav MM; Kutty MK
    Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis.
    Caputi M; De Luca L; Papaccio G; D'Aponte A; Cavallotti I; Scala P; Scarano F; Manna M; Gualdiero L; De Luca B
    Eur J Histochem; 1997; 41(2):133-8. PubMed ID: 9271706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
    Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix.
    Ho DM; Hsu CY; Chiang H
    Gynecol Oncol; 2000 Jan; 76(1):97-102. PubMed ID: 10620448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
    Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
    Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma.
    Frierson HF; Gaffey MJ; Zukerberg LR; Arnold A; Williams ME
    Mod Pathol; 1996 Jul; 9(7):725-30. PubMed ID: 8832554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma.
    Migita T; Oda Y; Naito S; Tsuneyoshi M
    Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin alterations in giant cell tumor of bone.
    Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R
    Mod Pathol; 2003 Mar; 16(3):210-8. PubMed ID: 12640100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.
    Samejima R; Kitajima Y; Yunotani S; Miyazaki K
    Anticancer Res; 1999; 19(6C):5515-21. PubMed ID: 10697609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.
    Takano Y; Kato Y; Masuda M; Ohshima Y; Okayasu I
    J Pathol; 1999 Oct; 189(2):194-200. PubMed ID: 10547574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma.
    Matsumoto M; Furihata M; Ohtsuki Y; Sasaguri S; Ogoshi S
    Anticancer Res; 2000; 20(3B):1947-52. PubMed ID: 10928132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
    Aoyagi S; Akiyama M; Shimizu H
    J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
    Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.